
Estrogen receptor modulator 1
CAS No. 63676-22-2
Estrogen receptor modulator 1( —— )
Catalog No. M24648 CAS No. 63676-22-2
Estrogen receptor modulator 1 causes regression of Tamoxifen-resistant, hormone-independent xenograft tumors. Estrogen receptor modulator 1 is an orally active and selective estrogen receptor modulator (SERM) (pIC50: 0.46).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 61 | In Stock |
![]() ![]() |
10MG | 102 | In Stock |
![]() ![]() |
25MG | 169 | In Stock |
![]() ![]() |
50MG | 255 | In Stock |
![]() ![]() |
100MG | 380 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameEstrogen receptor modulator 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionEstrogen receptor modulator 1 causes regression of Tamoxifen-resistant, hormone-independent xenograft tumors. Estrogen receptor modulator 1 is an orally active and selective estrogen receptor modulator (SERM) (pIC50: 0.46).
-
DescriptionEstrogen receptor modulator 1 causes regression of Tamoxifen-resistant, hormone-independent xenograft tumors. Estrogen receptor modulator 1 is an orally active and selective estrogen receptor modulator (SERM) (pIC50: 0.46).
-
In VitroEstrogen receptor modulator 1 (compound 18) (100 nM; 10 days)inhibits T47D:A18/PKCα and T47D:A18-TAM1 colony formation.Estrogen receptor modulator 1 (100 nM; 9 days) significantly inhibits the growth of MCF-7:5C cell, and induces apoptosis in these cells 6 days. Cell Proliferation Assay Cell Line:T47D:A18/PKCα and T47D:A18-TAM1 cells Concentration:100 nM Incubation Time:10 days Result:Inhibit T47D:A18/PKCα and T47D:A18-TAM1 colony formation.Cell Viability Assay Cell Line:MCF-7:5C cells Concentration:100 nM Incubation Time:9 days Result:Significantly inhibited the growth of MCF-7:5C cells.
-
In VivoEstrogen receptor modulator 1 (1.5 mg/animal; p.o. ; daily for 2 weeks) results in regression of T47D:A18/PKCα tumors. Animal Model:4-6 week old athymic mice (Harlan-Sprague-Dawley) Dosage:1.5 mg/animal Administration:p.o. ; daily for 2 weeks Result:Significantly reduced tumor volume.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
RecptorEstrogen Receptor/ERR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number63676-22-2
-
Formula Weight242.29
-
Molecular FormulaC14H10O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESOC1=CC=C(C=C(C2=CC=C(O)C=C2)S3)C3=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Brogi S, et al. 3D-QSAR using pharmacophore-based alignment and virtual screening for discovery of novel MCF-7 cell line inhibitors. Eur J Med Chem. 2013 Sep;67:344-51.
molnova catalog



related products
-
Enclomiphene citrate
Enclomiphene citrate((E)-Clomifene, cis-Clomifene, RMI-16289, ICI-46476)?is a nonsteroidal selective estrogen receptor modulator (SERM) that is under development for the treatment of male hypogonadism.
-
(R)-Equol
(R)-Equol is an ERα and ERβ agonist with Kis of 27.4 and 15.4 nM, respectively.
-
PROTAC ERRα ligand 2
PROTAC ERRα ligand 2 is an estrogen-related receptor α (ERRα) inverse agonist( IC50 : 5.67 nM)